1. Home
  2. SEPN vs BOW Comparison

SEPN vs BOW Comparison

Compare SEPN & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • BOW
  • Stock Information
  • Founded
  • SEPN 2022
  • BOW 2020
  • Country
  • SEPN United States
  • BOW United States
  • Employees
  • SEPN N/A
  • BOW N/A
  • Industry
  • SEPN
  • BOW Property-Casualty Insurers
  • Sector
  • SEPN
  • BOW Finance
  • Exchange
  • SEPN NYSE
  • BOW Nasdaq
  • Market Cap
  • SEPN 1.0B
  • BOW 880.2M
  • IPO Year
  • SEPN 2024
  • BOW 2024
  • Fundamental
  • Price
  • SEPN $22.53
  • BOW $33.51
  • Analyst Decision
  • SEPN
  • BOW Hold
  • Analyst Count
  • SEPN 0
  • BOW 5
  • Target Price
  • SEPN N/A
  • BOW $31.40
  • AVG Volume (30 Days)
  • SEPN 399.2K
  • BOW 350.3K
  • Earning Date
  • SEPN 11-26-2024
  • BOW 11-05-2024
  • Dividend Yield
  • SEPN N/A
  • BOW N/A
  • EPS Growth
  • SEPN N/A
  • BOW 130.44
  • EPS
  • SEPN N/A
  • BOW 1.08
  • Revenue
  • SEPN $838,000.00
  • BOW $389,135,000.00
  • Revenue This Year
  • SEPN N/A
  • BOW N/A
  • Revenue Next Year
  • SEPN N/A
  • BOW $31.08
  • P/E Ratio
  • SEPN N/A
  • BOW $31.03
  • Revenue Growth
  • SEPN N/A
  • BOW 107.43
  • 52 Week Low
  • SEPN $18.62
  • BOW $22.14
  • 52 Week High
  • SEPN $26.34
  • BOW $34.49
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • BOW N/A
  • Support Level
  • SEPN N/A
  • BOW N/A
  • Resistance Level
  • SEPN N/A
  • BOW N/A
  • Average True Range (ATR)
  • SEPN 0.00
  • BOW 0.00
  • MACD
  • SEPN 0.00
  • BOW 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • BOW 0.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc is engaged in providing specialty P&C products. It is a specialty insurance group that generates revenues by underwriting and offering a variety of specialty insurance products to domestic markets through three distinct underwriting divisions: Casualty, Professional Liability and Healthcare. Casualty specialize in GL coverage for risks in the construction, distribution, heavy manufacturing, real estate and hospitality segments and also consider underwriting risks in a broader range of industries. Key revenue is generated from Casualty segment.

Share on Social Networks: